Cooper Financial Group Novo Nordisk A S Transaction History
Cooper Financial Group
- $808 Million
- Q4 2024
A detailed history of Cooper Financial Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Cooper Financial Group holds 11,072 shares of NVO stock, worth $914,768. This represents 0.12% of its overall portfolio holdings.
Number of Shares
11,072
Previous 10,479
5.66%
Holding current value
$914,768
Previous $1.25 Million
23.66%
% of portfolio
0.12%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,870Shares Held
318MCall Options Held
5.49MPut Options Held
7.77M-
Jennison Associates LLC19.9MShares$1.65 Billion1.06% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.19 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.18 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.1 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.01 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...